Point of Care Nano-Technology, Inc.

2022 Q4 Form 10-K Financial Statement

#000119983522000608 Filed on October 25, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.850K $3.200K $100.00
YoY Change
Cash & Equivalents $5.849K $3.198K $100.00
Short-Term Investments
Other Short-Term Assets $1.170K $2.920K
YoY Change
Inventory
Prepaid Expenses $1.167K $2.917K
Receivables $100.0K
Other Receivables $0.00
Total Short-Term Assets $7.016K $6.115K $100.1K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $122.3K $123.5K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $122.3K $123.5K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.016K $6.115K $100.1K
Total Long-Term Assets $122.3K $123.5K $0.00
Total Assets $129.3K $129.6K $100.1K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $231.2K $213.3K $92.23K
YoY Change 269.91% 954.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $231.2K $213.3K $182.2K
YoY Change 269.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $231.2K $213.3K $182.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $231.2K $213.3K $182.2K
YoY Change 269.91% 954.03%
SHAREHOLDERS EQUITY
Retained Earnings -$120.3M -$120.3M
YoY Change 0.05%
Common Stock $940.00 $940.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $520.00 $520.00
YoY Change
Treasury Stock Shares 520.0K shares 520.0K shares 520.0K shares
Shareholders Equity -$101.8K -$83.75K -$82.13K
YoY Change
Total Liabilities & Shareholders Equity $129.3K $129.6K $100.1K
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Officers Compensation
OfficersCompensation
usd
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2021 us-gaap Officers Compensation
OfficersCompensation
usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 pcnt License Fee To Be Paid In Common Shares
LicenseFeeToBePaidInCommonShares
usd
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2021 pcnt License Fee To Be Paid In Common Shares
LicenseFeeToBePaidInCommonShares
usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-07-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56356
CY2022 dei Entity Registrant Name
EntityRegistrantName
POINT OF CARE NANO-TECHNOLOGY INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2830681
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
109 Ambersweet Way
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Davenport
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33897
CY2022 dei City Area Code
CityAreaCode
(732)
CY2022 dei Local Phone Number
LocalPhoneNumber
723-7395
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
940621 shares
CY2022 dei Auditor Name
AuditorName
K. R.
CY2022 dei Auditor Location
AuditorLocation
Vancouver, Canada 
CY2022 dei Auditor Firm
AuditorFirmId
1212
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3198 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2917 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
6115 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
123466 usd
CY2022Q3 us-gaap Assets
Assets
129581 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
213335 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
20240 usd
CY2022Q3 us-gaap Liabilities
Liabilities
213335 usd
CY2021Q3 us-gaap Liabilities
Liabilities
20240 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
940621 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
940621 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
940621 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
940621 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
940 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
940 usd
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
520000 shares
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001504239
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q1 dei Entity Public Float
EntityPublicFloat
2820000 usd
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
usd
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2021Q3 us-gaap Assets
Assets
usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2021 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
usd
CY2021 us-gaap Royalty Expense
RoyaltyExpense
usd
CY2021 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
520 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120191707 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120191187 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120275882 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120212367 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-83754 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-20240 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129581 usd
CY2022 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
100000 usd
CY2022 us-gaap Royalty Expense
RoyaltyExpense
90000 usd
CY2022 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
10000 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
51800 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
7500 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20180 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1534 usd
CY2022 us-gaap Officers Compensation
OfficersCompensation
1 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
73515 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
7500 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-63515 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7500 usd
CY2022 pcnt Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.08
CY2021 pcnt Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.00
CY2022 pcnt Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
787183 shares
CY2021 pcnt Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
940621 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-20240 usd
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-42255 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-62494 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-13795 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-76289 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5837 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-82126 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1628 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-83754 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-12740 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-12740 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-12740 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-12740 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7500 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-20240 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-63515 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7500 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1534 usd
CY2022 us-gaap Officers Compensation
OfficersCompensation
1 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2917 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
68095 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7500 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3198 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3198 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3198 usd
CY2022 pcnt License Fee To Be Paid In Common Shares
LicenseFeeToBePaidInCommonShares
125000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120275882 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3198 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_z2XIYG6knIEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_860_zKAodUbWboxa">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management.  Actual results could differ from those estimates. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1750000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2546 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2546 pure
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
462000 usd
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
446000 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
462000 usd
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
446000 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On June 8, 2022, the Company received approval from the Financial Industry Regulatory Authority to effect a 50:1 reverse split of the Company’s outstanding common stock.
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000 shares
CY2022 pcnt License Fee To Be Paid In Common Shares
LicenseFeeToBePaidInCommonShares
125000 usd
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
520000 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
520000 shares
CY2022 pcnt Disclosure License Purchased And Intangible Assets Details Abstract
DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract
<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract_zrk46zjKKN02" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"/><td/> <td style="white-space: nowrap; text-align: center"/> <td id="xdx_492_20210801__20220731_zXAvHo6NfWi9" style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td id="xdx_496_20200801__20210731_z25PjuHD3Hr" style="white-space: nowrap; text-align: center"/><td/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td> </td> <td colspan="6" style="white-space: nowrap; text-align: center">As of July 31</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_401_ecustom--LicenseFeeToBePaidInCommonShares_zXd1RxVZ01F6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 54%; text-align: justify">License</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">125,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">-</span></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DepreciationAndAmortization_zwFFw1VkCaRe" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,534</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0410">-</span></td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iE_zaR9uUbaUKW4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance, end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">123,466</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022 pcnt License Fee To Be Paid In Common Shares
LicenseFeeToBePaidInCommonShares
125000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1534 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
123466 usd
CY2022Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
100000 usd
CY2022Q2 us-gaap Royalty Expense
RoyaltyExpense
90000 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1813968 usd
CY2022 pcnt Disclosure Income Taxes Details Abstract
DisclosureIncomeTaxesDetailsAbstract
<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureIncomeTaxesDetailsAbstract_z558DKDh8hi6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"/><td/> <td style="white-space: nowrap; text-align: center"/> <td id="xdx_49B_20210801__20220731_zXy0qYEv26da" style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td id="xdx_496_20200801__20210731_z802Wi8gsWDd" style="white-space: nowrap; text-align: center"/><td/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Year Ended July 31</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_zsUgwCopqghd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: justify">Net loss for the year</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(63,515</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(7,500</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_zUyVNEviRxE9" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Statutory and effective tax rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25.46</td><td style="white-space: nowrap; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25.46</td><td style="white-space: nowrap; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzilS_zYSiwTTTzWqf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected income tax recovery</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(16,162</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(1,909</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_di_maITEBzilS_zXjDWKMzutZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Tax benefit deferred</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">16,162</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,909</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzilS_zhY78GRNyVJc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Income taxes recorded</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0438">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-63515 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7500 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2546 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2546 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-16162 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1909 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-16162 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1909 usd
CY2022 pcnt Disclosure Income Taxes Details2 Abstract
DisclosureIncomeTaxesDetails2Abstract
<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--DisclosureIncomeTaxesDetails2Abstract_zmJb5jOIkgM" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"/><td/> <td style="white-space: nowrap; text-align: center"/> <td id="xdx_498_20210801__20220731_zU84TX7M39hg" style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td style="white-space: nowrap; text-align: center"/> <td id="xdx_498_20200801__20210731_z20efNsAc3wi" style="white-space: nowrap; text-align: center"/><td/></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td> </td> <td colspan="6" style="white-space: nowrap; text-align: center">Year Ended July 31</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iE_zJ1ezL6OGpX2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: justify">Tax losses carried forward</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,814,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,750,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_z7NGl6Gw5qih" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Statutory and effective tax rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25.46</td><td style="white-space: nowrap; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25.46</td><td style="white-space: nowrap; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_iE_maDTANzWY4_zTcLQyvxips3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Deferred tax asset</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">462,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">446,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNE_di_msDTANzWY4_zGrn81eKi7Fk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(462,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(446,000</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsNet_iE_mtDTANzWY4_zw5GXQIBG8s3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1814000 usd

Files In Submission

Name View Source Status
0001199835-22-000608-index-headers.html Edgar Link pending
0001199835-22-000608-index.html Edgar Link pending
0001199835-22-000608.txt Edgar Link pending
0001199835-22-000608-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcnt-10k.htm Edgar Link pending
pcnt-20220731.xsd Edgar Link pending
pcnt-ex31.htm Edgar Link pending
pcnt-ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pcnt-20220731_cal.xml Edgar Link unprocessable
pcnt-20220731_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pcnt-20220731_lab.xml Edgar Link unprocessable
pcnt-20220731_def.xml Edgar Link unprocessable
pcnt-10k_htm.xml Edgar Link completed